Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker

Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker

Objective: To assess 4 adverse renal outcomes in a heterogeneous cohort of patients with systolic heart failure (HF) who were prescribed sacubitril-valsartan vs angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEi/ARB). Patients and Methods: The OptumLabs Database Warehouse, wh...

Full description

Bibliographic Details
Main Authors: Nicholas Y. Tan, MD, MS, Yihong Deng, PhD, Xiaoxi Yao, PhD, MPH, Lindsey R. Sangaralingham, MPH, Nilay D. Shah, PhD, Andrew D. Rule, MD, John C. Burnett, Jr., MD, Shannon M. Dunlay, MD, MS, S. Jeson Sangaralingham, MS, PhD
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454820302083

Internet

http://www.sciencedirect.com/science/article/pii/S2542454820302083

Similar Items